Rotator cuff injury
Conditions
Interventions
Autologous PRP therapy:Autologous PRP 10mL was injected 1 day before discharge and 3 weeks after discharge after arthroscopic shoulder repair, a total of two times
corticosteroid treatment group:Two injections of betamethasone (Deproxone) 5 mg/1 mL + ropivacaine 2 mL + saline 7 mL for a total of 10 mL mixture 1 day before discharge and 3 weeks after discharge af
saline control group:1 day before discharge and 3 weeks after discharge after arthroscopic shoulder repair, inject 10 mL of normal saline twice in total
Sponsors
Wang Rui
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Aged between 18-75 years old, no history of systemic or metabolic diseases; symptoms such as rotator cuff injury (including synovitis, rotator cuff tendinopathy, rotator cuff tear) and recent magnetic resonance examination (MRI) ) was confirmed; pain after arthroscopic rotator cuff repair within the last three months; no neuromuscular disease or other disorders that may affect muscle structure and echo; no family history of disease.
Exclusion criteria
Exclusion criteria: Less than 18 years of age; patients with shoulder pain without rotator cuff injury; previous non-invasive treatment, including treatment with NSAIDs and PRP and/or regular exercise and/or physical therapy for at least 2 months (TENS, ultrasound, etc.); allergic reactions to disinfectants, anesthetics, sodium citrate, and calcium chloride, etc.; thrombocytopenia, acute and chronic infections, anticoagulant therapy, etc.; previous adverse reactions to local injections (hypertension, systemic allergy, and hypersensitivity reactions), or even severe kidney or liver disease, etc.); pregnancy, malignancy, etc. within 6-12 weeks after minimally invasive treatment; patients with severe osteoporosis near the joints; patients who cannot maintain follow-up or provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Constant-Murley,constant; | — |
Secondary
| Measure | Time frame |
|---|---|
| visual analogue scale,VAS;University LosAngeles,UCLA scoring system;Common Terminology Criteria for Adverse Events,CTCAE;two-dimensional ultrasound;MRI; | — |
Countries
China
Contacts
Public ContactZhang Qiang
Outcome results
None listed